KLDO - Kaleido Biosciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KLDO is currently covered by 1 analysts with an average price target of $3.01. This is a potential upside of $3.01 (0%) from yesterday's end of day stock price of $0.

Kaleido Biosciences's activity chart (see below) currently has 15 price targets and 11 ratings on display. The stock rating distribution of KLDO is 100% HOLD.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 40% with an average time for these price targets to be met of 35.4 days.

Highest price target for KLDO is $2, Lowest price target is $2, average price target is $3.01.

Most recent stock forecast was given by KEAY NAKAE from CHARDAN CAPITAL on 04-Apr-2022. First documented stock forecast 25-Mar-2019.

Best performing analysts who are covering KLDO - Kaleido Biosciences:

Matthew Harrison Keay Nakae Edward Tenthoff Jessica Fye Gobind Singh

Currently out of the existing stock ratings of KLDO, 1 are a HOLD (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

$1.7

$1.7 (0.00%)

$3

2 years 9 months ago
(04-Apr-2022)

0/3 (0%)

$0.06 (3.66%)

Buy

$4

$4 (0.00%)

$19

2 years 11 months 7 days ago
(28-Jan-2022)

0/2 (0%)

$2.26 (129.89%)

Buy

$22

$22 (0.00%)

$22

3 years 2 months 1 days ago
(03-Nov-2021)

0/2 (0%)

$14.82 (247.54%)

Sell

$3

$3 (0.00%)

$8

3 years 2 months 15 days ago
(20-Oct-2021)

6/6 (100%)

$-1.56 (-34.21%)

78

Sell

$5

$5 (0.00%)

$10

3 years 6 months 19 days ago
(16-Jun-2021)

2/2 (100%)

$-0.55 (-9.42%)

99

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KLDO (Kaleido Biosciences) average time for price targets to be met?

On average it took 35.4 days on average for the stock forecasts to be realized with a an average price target met ratio 40

Which analyst has the current highest performing score on KLDO (Kaleido Biosciences) with a proven track record?

MATTHEW HARRISON

Which analyst has the current lower performing score on KLDO (Kaleido Biosciences) with a proven track record?

GOBIND SINGH

Which analyst has the most public recommendations on KLDO (Kaleido Biosciences)?

Matthew Harrison works at MORGAN STANLEY and has 8 price targets and 5 ratings on KLDO

Which analyst is the currently most bullish on KLDO (Kaleido Biosciences)?

Gobind Singh with highest potential upside - $22

Which analyst is the currently most reserved on KLDO (Kaleido Biosciences)?

Keay Nakae with lowest potential downside - $1.7

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?